Spatial profiling predicts Hodgkin lymphoma recurrence following bone marrow transplant.

Cedars-Sinai Cancer investigators have made a significant breakthrough in predicting the recurrence of immune system cancer in patients treated with a bone marrow transplant. This study, published in the Journal of Clinical Oncology, utilizes a novel technique called spatial profiling to predict patient outcomes, potentially leading to more targeted treatment. The research focused on Hodgkin lymphoma, a cancer that affects the lymphatic system, and analyzed biopsies from 169 patients. By examining the cells and tissues surrounding tumors, researchers were able to accurately predict how the cancer would respond to a transplant using the patient’s own stem cells. This discovery could help identify patients who are likely to remain disease-free after a stem cell transplant, sparing them from additional potentially life-threatening therapies.

Dr. Akil Merchant, co-director of the Lymphoma Program at Cedars-Sinai, emphasized the accuracy of their new method in predicting treatment response, surpassing current leading-edge techniques. This study also demonstrated the adaptability of spatial profiling for a clinical setting, with potential application across different types of cancer. The researchers further highlighted the value of a quantitative tool like this in maintaining consistent results from patient to patient and clinic to clinic.

Moving forward, the team plans to develop a clinical test based on their findings. They are also exploring the creation of similar predictive tests for other cancer types. This groundbreaking research has the potential to revolutionize cancer treatment, providing precise and targeted therapies to an increasing number of patients.

Help improve our content system

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

Share this story:

Transplant News
Transplant News

Transplant News brings you the news and content that matters to the transplant community. From patient stories, to the latest in transplant innovation, Transplant News is your window into the world of transplantation.